BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 37337737)

  • 21. The Many Faces of Immune Checkpoint Inhibitor-Associated Pneumonitis: 4 Case Reports.
    Mojsak D; Dębczyński M; Kuklińska B; Moniuszko-Malinowska A; Mróz RM
    Am J Case Rep; 2022 Jun; 23():e936420. PubMed ID: 35648729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent delayed immune-related pneumonitis after immune-checkpoint inhibitor therapy for advanced osteosarcoma.
    Küçükarda A; Gökmen İ; Özcan E; Peker P; Akgül F; Çiçin İ
    Immunotherapy; 2022 Apr; 14(6):395-399. PubMed ID: 35152716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons from the diagnosis and treatment of severe immune checkpoint inhibitor-associated pneumonia: a case report.
    Weng F; Wei J; Sang M; Gao X; Zhang P; Fu Q
    Immunotherapy; 2023 Aug; 15(12):897-903. PubMed ID: 37337737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune checkpoint inhibitor-related chronic pneumonitis: a case report and literature review.
    Yuan-Di Wang ; Yuan S; Wen C; Ji Z; Xiang B; Wang B; Zhang Z
    Immunotherapy; 2023 Oct; 15(14):1117-1123. PubMed ID: 37431609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune-related pneumonitis caused by programmed death-1 inhibitor Pembrolizumab: a case report and literature review].
    Chen YL; Zhao J; Jia R; Wang HY; Zheng J; Bai CQ; Wang MZ; Xu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):736-743. PubMed ID: 29050127
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non-Small-Cell Lung Cancer.
    Naidoo J; Nishino M; Patel SP; Shankar B; Rekhtman N; Illei P; Camus P
    Clin Lung Cancer; 2020 Sep; 21(5):e435-e444. PubMed ID: 32576443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune-related organizing pneumonitis in non-small cell lung cancer receiving PD-1 inhibitor treatment: A case report and literature review.
    Yin B; Xiao J; Li J; Liu X; Wang J
    J Cancer Res Ther; 2020; 16(7):1555-1559. PubMed ID: 33565499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune Checkpoint Inhibitor-Related Pneumonitis.
    Gomatou G; Tzilas V; Kotteas E; Syrigos K; Bouros D
    Respiration; 2020; 99(11):932-942. PubMed ID: 33260191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis.
    Wang H; Guo X; Zhou J; Li Y; Duan L; Si X; Zhang L; Liu X; Wang M; Shi J; Zhang L
    Thorac Cancer; 2020 Jan; 11(1):191-197. PubMed ID: 31762218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumonitis associated with immune checkpoint inhibitors among patients with non-small cell lung cancer.
    Shannon VR
    Curr Opin Pulm Med; 2020 Jul; 26(4):326-340. PubMed ID: 32452900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1
Antibody-Safety and Effectiveness of Pirfenidone].
    Yu H; Li J; Yu L; Cheng X; Han X; Zhang X
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):519-525. PubMed ID: 34134189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management.
    Zhang Q; Tang L; Zhou Y; He W; Li W
    Front Immunol; 2021; 12():663986. PubMed ID: 34122422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor].
    Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Li Y; Liu X; Wang M; Shi J; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Oct; 22(10):621-626. PubMed ID: 31650943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case report and literature review of immune checkpoint inhibitor-associated pneumonia caused by penpulimab.
    Gao R; Yang F; Yang C; Zhang Z; Liu M; Xiang C; Hu H; Luo X; Li J; Liu R
    Front Immunol; 2023; 14():1114994. PubMed ID: 37426639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical applications of radiomics in non-small cell lung cancer patients with immune checkpoint inhibitor-related pneumonitis.
    Shu Y; Xu W; Su R; Ran P; Liu L; Zhang Z; Zhao J; Chao Z; Fu G
    Front Immunol; 2023; 14():1251645. PubMed ID: 37799725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare case of miliary tuberculosis in a patient with NSCLC receiving PD1 inhibitor therapy, mimicking autoimmune pneumonitis.
    Nikola N; Natasa D; Milica K
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S909-S911. PubMed ID: 38384077
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.